GENOWAY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.08 EUR | +1.24% |
|
-0.49% | -11.30% |
| 2023 | GenOway: sharp rise, broker initiates buy recommendation | CF |
| 2023 | GENOWAY : Euroland initiates buy coverage | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 3.88Cr | - | - | - | - | - | |
| 4.69TCr | - | |||||
| 3.91TCr | ||||||
| 3.85TCr | ||||||
| 3.1TCr | - | |||||
| 2.61TCr |
- Stock Market
- Equities
- ALGEN Stock
- Charts genOway
- Sector Chart
